38226 Car-t prep t lymphcyt f/trns
Surgery
Also known as: CAR-T manufacturing, T-cell modification
Preparation and genetic modification of T lymphocytes for chimeric antigen receptor T-cell therapy including transduction and expansion.
Clinical Context
Manufacturing phase of CAR-T therapy involving transduction of T cells with CAR construct and ex vivo expansion.
RVU Breakdown
| Work RVU | 0.77 |
| Practice Expense RVU | 0.17 |
| Malpractice RVU | 0.07 |
| Total RVU | 1.01 |
Est. Medicare Payment
$33.73
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.